Follow
Beatriz Domingues
Beatriz Domingues
Unknown affiliation
Verified email at i3bs.uminho.pt
Title
Cited by
Cited by
Year
Melanoma treatment in review
B Domingues, JM Lopes, P Soares, H Pópulo
ImmunoTargets and therapy 7, 35, 2018
7262018
Future directions for ureteral stent technology: from bench to the market
B Domingues, M Pacheco, JE de la Cruz, I Carmagnola, ...
Advanced Therapeutics 5 (1), 2100158, 2022
112022
Bioinks enriched with ECM components obtained by supercritical extraction
DP Reis, B Domingues, C Fidalgo, RL Reis, L Gasperini, AP Marques
Biomolecules 12 (3), 394, 2022
72022
Helena Pópulo
B Domingues, JM Lopes, P Soares
Melanoma treatment in review. Immunotargets Ther 7, 35-49, 2018
72018
Coatings for Urinary Stents: Current State and Future Directions
B Domingues, JM Silva, IM Aroso, E Lima, AA Barros, RL Reis
Urinary Stents: Current State and Future Perspectives, 209-223, 2022
42022
Combinatorial therapies to overcome BRAF/MEK inhibitors resistance in melanoma cells: an in vitro study
H Pópulo, B Domingues, C Sampaio, JM Lopes, P Soares
Journal of experimental pharmacology, 521-535, 2021
42021
Hydrogels as stents
M Pacheco, B Domingues, E Lima, RL Reis, A Barros
Hydrogels for Tissue Engineering and Regenerative Medicine, 467-482, 2024
2024
Biodegradable and electrically responsive polymer hydrogel as a drug delivery system to manage ureteral stent-associated pain
B Domingues, E Silva, E Lima, AA Barros, RL Reis
TISSUE ENGINEERING PART A 29 (13-14), 2023
2023
Internal and external metal-based coatings to prevent uropathogen adhesion on stents
B Domingues, IM Aroso, E Lima, A Barros, RL Reis
EUROPEAN UROLOGY 79, S197-S198, 2021
2021
Metabolic modulation combined with mTOR pathway inhibition may overcame cutaneous melanoma resistance to MAPK inhibitors treatment
C Sampaio, B Domingues, P Soares, JM Lopes, H Pópulo
European Journal of Cancer 138, S23, 2020
2020
Method of post-manufacture impregnation to create a drug-eluting stent - ENIUS. European Network of multidisciplinary research to Improve the Urinary Stents. COSTS Actions …
B Domingues, IM Aroso, E Lima, AA Barros, RL Reis
Urolithiasis 48, 553–559, 2020
2020
Possible therapies to overcome resistance to MAPK inhibitors in mutant BRAF melanoma
BB Domingues
2018
The system can't perform the operation now. Try again later.
Articles 1–12